Who Approves Mergers the Governmental Review Process

The approval of mergers in the United States occurs through a structured governmental review process designed to preserve competition and consumer welfare. The key players are federal antitrust agencies, led by the Federal Trade Commission (FTC) and the Department of Justice (DOJ), which scrutinize proposed mergers for potential anticompetitive effects. This article explains who approves mergers, how the process works, and the steps and remedies typically involved, with a focus on the most common U.S. framework that governs major business combinations.

Overview Of The Merger Review Landscape

Merger approvals hinge on antitrust law and established enforcement practices. The Federal Trade Commission and the Department of Justice share responsibility for reviewing mergers that may substantially lessen competition, create monopoly, or otherwise harm consumers. The agencies coordinate on many cases, though they independently bring actions or negotiate settlements when warranted. The review process often begins before formal enforcement actions, using market analysis, financial data, and competitive dynamics to determine whether a transaction should proceed, be modified, or be blocked.

Key Agencies Involved In Merger Review

The two primary U.S. federal authorities are:

• Federal Trade Commission (FTC): The FTC investigates mergers to assess impacts on competition, focusing on consumer welfare, market structure, and potential price effects. The FTC can sue to block a merger or accept settlements that impose conditions.
• Department Of Justice Antitrust Division (DOJ): The DOJ analyzes whether a merger would substantially lessen competition and can also challenge deals in court or negotiate consent decrees that impose behavioral or structural remedies.

In some cases, both agencies have jurisdiction, leading to parallel investigations. When enforcers conclude a transaction may substantially lessen competition, they may pursue a settlement with remedies or, in rare cases, block the deal entirely. State attorneys general can also review mergers that implicate state interests and may sue to block or modify deals within their jurisdictions.

Foundational Step: The Hart-Scott-Rodino Act

The Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) requires large mergers to be disclosed to the federal competition authorities before closing. This premerger notification provides agencies a head start to study the anticipated market effects and to prepare for potential enforcement actions. Filing thresholds are based on annual sales, and failing to file or timing issues can trigger penalties or unwinding of deals. The HSR process often leads to a second request for extensive documentation if initial information raises competitive concerns.

From Inquiry To Investigation: The Review Timeline

The typical merger review timeline includes several key phases. First, the parties prepare and file notices under the HSR Act. Second, agencies screen the filing to determine whether to issue a document request or second request for more detailed information. Third, agencies conduct a thorough analysis of market shares, potential coordination, entry barriers, and consumer impact. The duration of the review varies with deal complexity, data availability, and potential remedies. In complex cases, the process can extend months beyond the initial notifications.

Second Requests And Data Demands

When preliminary concerns arise, agencies issue a second request to assemble extensive data sets, including customer lists, supplier information, and internal analyses. The process requires significant cooperation from the merging parties and can extend the review period. The agencies use the gathered information to simulate market scenarios, assess competitive effects, and evaluate potential remedies. Timely and comprehensive responses are crucial to avoid delays or negative inferences about the deal’s impact on competition.

Remedies, Divestitures, And Settlement Options

Most challenged mergers are resolved through remedies designed to maintain competitive conditions without blocking the transaction. Remedies can be:

• Divestitures: Requiring the sale of specific assets, product lines, or business units to preserve competition in relevant markets.
• Behavioral Remedies: Imposing conduct constraints, such as licensing agreements, non-discriminatory access to essential facilities, or pricing commitments.
• Combination Of Remedies: Some settlements impose a mix of divestitures and behavioral terms tailored to the market structure and customers involved.

Even after remedies are proposed, agencies may accept, reject, or modify them in negotiations. If a deal proceeds despite significant concerns, the agencies can sue to block the merger or pursue court-ordered remedies. Remedies aim to preserve competitive outcomes while allowing legitimate business integration to proceed.

What Happens If The Agencies Object Or Block A Merger

When the review concludes that a merger would substantially lessen competition, the government may file a lawsuit to block the deal or accept a consent decree with conditions. Courts review these actions under established antitrust standards, including whether the proposed transaction would reduce competition and harm consumers. In some instances, merged entities may retreat or restructure parts of the business to satisfy regulatory concerns and resubmit for approval.

Compliance, Negotiation, And Timing Considerations

Effective compliance calls for early informal discussions with enforcement authorities, sequencing the transaction to align with regulatory milestones, and a clear communications strategy. Parties often engage antitrust counsel to assess potential competitive risks, prepare data rooms for information requests, and negotiate remedies that minimize disruption to business operations. Timing is critical; initiating discussions early can reduce the risk of post-closing enforcement actions or costly divestitures.

Pathways For Appeals And Post-Closing Challenges

If a merger is challenged, parties may pursue administrative remedies or litigation to challenge the agencies’ determinations. Appeals typically involve considerations of whether the agencies’ analysis properly applied legal standards and whether remedies adequately addressed competitive concerns. Post-closing challenges may occur if markets fail to perform as anticipated or if new data reveals adverse effects on competition. Proactive remedy design and robust market testing can mitigate these risks.

Global Context And Cross-Border Considerations

While this article focuses on U.S. practice, many mergers have international dimensions. Other jurisdictions may require parallel approvals from competition authorities, affecting deal timetables and economic outcomes. Multinational mergers often involve coordinating filings across regulators such as the European Commission, the UK Competition and Markets Authority, and other national bodies. Global timelines can influence U.S. review strategies and remedies, especially when competition concerns extend beyond domestic markets.

Key Takeaways For Understanding Who Approves Mergers

• The FTC and DOJ are the primary U.S. authorities approving or blocking mergers through antitrust review.
• The Hart-Scott-Rodino Act provides the initial notification framework and time for agencies to assess potential harms.
• Second requests and in-depth data analyses are common for complex deals, shaping final outcomes.
• Remedies, including divestitures and behavioral commitments, are central to resolving competitive concerns without outright blockage.
• Timeliness, cooperation, and strategic remedy design influence the likelihood of regulatory approval.